Skip to main content
Lee-Collier-Charlotte
Business Observer Monday, Oct. 4, 2021 2 months ago

Medical group names new president, managing physician

Share
Dr. Michael Diaz has been with FCS for a decade.

FORT MYERS — St. Petersburg doctor Dr. Michael Diaz has been named president and managing physician of Florida Cancer Specialists & Research Institute. He will assume the position Jan. 1.

Diaz succeeds Dr. Lucio Gordan, who has served in that position since 2018, according to a statement. Gordan will continue to practice as a medical oncologist at the FCS Gainesville Cancer Center and serve as chief medical officer of therapeutics and analytics for the statewide practice, the release adds.

“Through his compassionate delivery of cancer care and his involvement in research, advocacy and philanthropic initiatives, (Diaz) works tirelessly to ensure that cancer patients in the Tampa Bay region and across Florida and the U.S. have ready access to affordable, high quality cancer care in their local communities,” FCS CEO Nathan Walcker says in the release. “He is ideally suited to fill this executive leadership role and lead our practice forward.”

Diaz joined FCS in 2011 and provides care at two FCS office locations in St. Petersburg. He has served as assistant managing physician for the statewide practice since November 2018. He currently serves on the FCS Executive Board and, for the past seven years, as director of patient advocacy. A recognized leader in advocating on behalf of cancer patients, he is a frequent presence in Tallahassee and in Washington, D.C., according to the statement, “working to ensure that cancer patients have access to state of the art, affordable cancer care that is close to home.”

Gordan frequently participates in national and international meetings as a speaker and key thought leader, and will remain actively engaged in clinical studies, the release states. “The achievements we have made over the last three years under Dr. Gordan’s leadership have been very substantial, practice-transforming, and enhancing,” Walcker says in the statement. “We are stronger than ever in all measurable aspects and we are grateful that Dr. Gordan will continue to contribute to future successes and innovations in this newly-created leadership role.”

“I am proud of the many milestones that we have accomplished to position our organization for future success for years to come,” Gordan says. “Dr. Diaz is an extraordinary individual, physician, and experienced leader in community oncology. He is well-respected nationally and we are very fortunate that he has agreed to take my place in this leadership position. FCS will be in the most capable hands with him, the Executive Board, other physician leaders, and our executive and senior management.”

 

Related Stories

Advertisement